Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models

Endocrine-disrupting chemicals (EDCs) are chemical substances that can interfere with the normal function of the endocrine system. EDCs are ubiquitous and can be found in a variety of consumer products such as food packaging materials, personal care and household products, plastic additives, and fla...

Full description

Bibliographic Details
Main Authors: Ruba Al-Abdulla, Hilda Ferrero, Sergi Soriano, Talía Boronat-Belda, Paloma Alonso-Magdalena
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/8/4182
_version_ 1797434535253639168
author Ruba Al-Abdulla
Hilda Ferrero
Sergi Soriano
Talía Boronat-Belda
Paloma Alonso-Magdalena
author_facet Ruba Al-Abdulla
Hilda Ferrero
Sergi Soriano
Talía Boronat-Belda
Paloma Alonso-Magdalena
author_sort Ruba Al-Abdulla
collection DOAJ
description Endocrine-disrupting chemicals (EDCs) are chemical substances that can interfere with the normal function of the endocrine system. EDCs are ubiquitous and can be found in a variety of consumer products such as food packaging materials, personal care and household products, plastic additives, and flame retardants. Over the last decade, the impact of EDCs on human health has been widely acknowledged as they have been associated with different endocrine diseases. Among them, a subset called metabolism-disrupting chemicals (MDCs) is able to promote metabolic changes that can lead to the development of metabolic disorders such as diabetes, obesity, hepatic steatosis, and metabolic syndrome, among others. Despite this, today, there are still no definitive and standardized in vitro tools to support the metabolic risk assessment of existing and emerging MDCs for regulatory purposes. Here, we evaluated the following two different pancreatic cell-based in vitro systems: the murine pancreatic β-cell line MIN6 as well as the human pancreatic β-cell line EndoC-βH1. Both were challenged with the following range of relevant concentrations of seven well-known EDCs: (bisphenol-A (BPA), bisphenol-S (BPS), bisphenol-F (BPF), perfluorooctanesulfonic acid (PFOS), di(2-ethylhexyl) phthalate (DEHP), cadmium chloride (CdCl<sub>2</sub>), and dichlorodiphenyldichloroethylene (DDE)). The screening revealed that most of the tested chemicals have detectable, deleterious effects on glucose-stimulated insulin release, insulin content, electrical activity, gene expression, and/or viability. Our data provide new molecular information on the direct effects of the selected chemicals on key aspects of pancreatic β-cell function, such as the stimulus-secretion coupling and ion channel activity. In addition, we found that, in general, the sensitivity and responses were comparable to those from other in vivo studies reported in the literature. Overall, our results suggest that both systems can serve as effective tools for the rapid screening of potential MDC effects on pancreatic β-cell physiology as well as for deciphering and better understanding the molecular mechanisms that underlie their action.
first_indexed 2024-03-09T10:33:42Z
format Article
id doaj.art-0c2e97ad27f24ac3905dc22225758e0f
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T10:33:42Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0c2e97ad27f24ac3905dc22225758e0f2023-12-01T21:02:45ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-04-01238418210.3390/ijms23084182Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro ModelsRuba Al-Abdulla0Hilda Ferrero1Sergi Soriano2Talía Boronat-Belda3Paloma Alonso-Magdalena4Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, 03202 Elche, SpainInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, 03202 Elche, SpainInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, 03202 Elche, SpainInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, 03202 Elche, SpainInstituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche (IDiBE), Universidad Miguel Hernández, 03202 Elche, SpainEndocrine-disrupting chemicals (EDCs) are chemical substances that can interfere with the normal function of the endocrine system. EDCs are ubiquitous and can be found in a variety of consumer products such as food packaging materials, personal care and household products, plastic additives, and flame retardants. Over the last decade, the impact of EDCs on human health has been widely acknowledged as they have been associated with different endocrine diseases. Among them, a subset called metabolism-disrupting chemicals (MDCs) is able to promote metabolic changes that can lead to the development of metabolic disorders such as diabetes, obesity, hepatic steatosis, and metabolic syndrome, among others. Despite this, today, there are still no definitive and standardized in vitro tools to support the metabolic risk assessment of existing and emerging MDCs for regulatory purposes. Here, we evaluated the following two different pancreatic cell-based in vitro systems: the murine pancreatic β-cell line MIN6 as well as the human pancreatic β-cell line EndoC-βH1. Both were challenged with the following range of relevant concentrations of seven well-known EDCs: (bisphenol-A (BPA), bisphenol-S (BPS), bisphenol-F (BPF), perfluorooctanesulfonic acid (PFOS), di(2-ethylhexyl) phthalate (DEHP), cadmium chloride (CdCl<sub>2</sub>), and dichlorodiphenyldichloroethylene (DDE)). The screening revealed that most of the tested chemicals have detectable, deleterious effects on glucose-stimulated insulin release, insulin content, electrical activity, gene expression, and/or viability. Our data provide new molecular information on the direct effects of the selected chemicals on key aspects of pancreatic β-cell function, such as the stimulus-secretion coupling and ion channel activity. In addition, we found that, in general, the sensitivity and responses were comparable to those from other in vivo studies reported in the literature. Overall, our results suggest that both systems can serve as effective tools for the rapid screening of potential MDC effects on pancreatic β-cell physiology as well as for deciphering and better understanding the molecular mechanisms that underlie their action.https://www.mdpi.com/1422-0067/23/8/4182metabolism-disrupting chemicalspancreatic β-celldiabetesmetabolic disordersinsulin secretionelectrical activity
spellingShingle Ruba Al-Abdulla
Hilda Ferrero
Sergi Soriano
Talía Boronat-Belda
Paloma Alonso-Magdalena
Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
International Journal of Molecular Sciences
metabolism-disrupting chemicals
pancreatic β-cell
diabetes
metabolic disorders
insulin secretion
electrical activity
title Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
title_full Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
title_fullStr Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
title_full_unstemmed Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
title_short Screening of Relevant Metabolism-Disrupting Chemicals on Pancreatic β-Cells: Evaluation of Murine and Human In Vitro Models
title_sort screening of relevant metabolism disrupting chemicals on pancreatic β cells evaluation of murine and human in vitro models
topic metabolism-disrupting chemicals
pancreatic β-cell
diabetes
metabolic disorders
insulin secretion
electrical activity
url https://www.mdpi.com/1422-0067/23/8/4182
work_keys_str_mv AT rubaalabdulla screeningofrelevantmetabolismdisruptingchemicalsonpancreaticbcellsevaluationofmurineandhumaninvitromodels
AT hildaferrero screeningofrelevantmetabolismdisruptingchemicalsonpancreaticbcellsevaluationofmurineandhumaninvitromodels
AT sergisoriano screeningofrelevantmetabolismdisruptingchemicalsonpancreaticbcellsevaluationofmurineandhumaninvitromodels
AT taliaboronatbelda screeningofrelevantmetabolismdisruptingchemicalsonpancreaticbcellsevaluationofmurineandhumaninvitromodels
AT palomaalonsomagdalena screeningofrelevantmetabolismdisruptingchemicalsonpancreaticbcellsevaluationofmurineandhumaninvitromodels